menu
    • menu

    Company profile for Catalyst Pharmaceuticals

    NEW Drugs in Dev: 5
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Catalyst is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating neuromuscular and neurological diseases.At Catalyst, we utilize leading-edge science in search of therapies that will improve the lives of those who suffer from rare-diseases, often without any therapeutic options. We believe that no other field of medicine holds as much promise and makes suc...
    Catalyst is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating neuromuscular and neurological diseases.At Catalyst, we utilize leading-edge science in search of therapies that will improve the lives of those who suffer from rare-diseases, often without any therapeutic options. We believe that no other field of medicine holds as much promise and makes such a significant impact on patents’ lives as the development of novel orphan drugs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Catalyst PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    355 Alhambra Circle, Suite 801 Coral Gables, FL 33134
    Telephone
    Telephone
    (305) 420-3200
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://catalystpharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/catalystforrare
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Angelini Strengthens Neurology Portfolio With $4.1B Catalyst
    Angelini Strengthens Neurology Portfolio With $4.1B Catalyst

    07 May 2026

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/italys-angelini-pharma-buy-catalyst-pharmaceuticals-41-billion-2026-05-07/

    REUTERS
    07 May 2026
    Share Share
    Catalyst Pharmaceuticals Cancels Q1 2026 Conference Call
    Catalyst Pharmaceuticals Cancels Q1 2026 Conference Call

    07 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/07/3290519/13009/en/catalyst-pharmaceuticals-cancels-first-quarter-2026-conference-call-and-webcast.html

    GLOBENEWSWIRE
    07 May 2026
    Share Share
    Catalyst Pharma To Release Q1 2026 Financial Results On May 11
    Catalyst Pharma To Release Q1 2026 Financial Results On May 11

    28 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/28/3282619/13009/en/catalyst-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-may-11-2026.html

    GLOBENEWSWIRE
    28 Apr 2026
    Share Share
    Italy's Angelini Said To Explore Catalyst Pharma Acquisition
    Italy's Angelini Said To Explore Catalyst Pharma Acquisition

    27 Apr 2026

    // BLOOMBERG

    https://www.bloomberg.com/news/articles/2026-04-27/italy-s-angelini-said-to-explore-acquisition-of-catalyst-pharma

    BLOOMBERG
    27 Apr 2026
    Share Share
    Catalyst Pharma Presents Duchenne Muscular Dystrophy Data
    Catalyst Pharma Presents Duchenne Muscular Dystrophy Data

    06 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/06/3251009/13009/en/Catalyst-Pharmaceuticals-to-Showcase-Real-World-Findings-in-Duchenne-Muscular-Dystrophy-and-Host-Vamorolone-Focused-Symposium-at-the-2026-MDA-Clinical-Scientific-Conference.html

    GLOBENEWSWIRE
    06 Mar 2026
    Share Share
    Catalyst Pharma Posts Record 2025 Results, Guides 2026 Finances
    Catalyst Pharma Posts Record 2025 Results, Guides 2026 Finances

    25 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/25/3245027/13009/en/Catalyst-Pharmaceuticals-Reports-Record-Fourth-Quarter-and-Record-Full-Year-2025-Financial-Results-and-Provides-2026-Financial-Guidance.html

    GLOBENEWSWIRE
    25 Feb 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search